NCT02590809View on ClinicalTrials.gov

Hypertrophic Cardiomyopathy Symptom Release by BX1514M

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 7, 2015

Primary Completion Date

July 6, 2016

Study Completion Date

July 6, 2016

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Treatment BX1514M

X mg x 3 /day of BX1514M for 15 days. Dosage will be then adapted, depending on symptoms release and walk distance test results for another 15 days period.

DRUG

Placebo

Placebo will be given for 30 days

OTHER

Walk distance test

Walk distance test during 6 minutes

OTHER

Exercise echocardiography

Trial Locations (1)

Unknown

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02590809 - Hypertrophic Cardiomyopathy Symptom Release by BX1514M | Biotech Hunter | Biotech Hunter